CLICK HERE
to download a PDF version of our Cytotron® &Haemoseis 256™ brochures.

CYTOTRON® & CANCER

RFQMR technology utilizes a totally different approach compared to conventional cancer treatment. Instead of the very high frequency ionising radiation used in radiotherapy, RFQMR uses radio or sub-radio frequency, low power, non-ionising, non thermal electromagnetic waves. The main concern of the therapy is not the immediate destruction of the cancer cells, but rather with the help of the small amount of energy provided to the cell to stop the DNA's uncontrolled mitosis, put the cell in a vegetative state and in time through apoptosis mechanism let the body get rid of the cancerous cells in a controlled fashion as all cells are programmed by nature for self destruction over time.

Several clinical studies show that changes in the transmembrane potential of the cells can have dramatic effects on the cell parameters including the ion concentration. RFQMR application helps to increase the transmembrane potential of the cancerous cells from the problematic -20 mV to the healthy -90 mV range. It is believed that the p53 proteins are activated and the uncontrolled mitosis of the cell comes to a halt by the RFQMR application.

RESULTS IN CANCER TREATMENT

A phase 1 clinical study has been held at the Institute of Aerospace Medicine in Bangalore India between 2004 and 2006 on more than 100 terminal cancer patients. All patients had undergone all possible conventional interventions such as chemo, radiotherapy or surgery prior to RFQMR. Nothing more could be offered and they were given few months to live. Out of such patients :

• In most of the patients the tumor progression was stopped or reversed
• 78.3% felt symptomatic relief (such as ease of pain, stop using pain killers, no more weight loss etc)
• More than 58% survived more than 1 year
• More than 33.3% went back to normal lives and living disease free for 2 years

As all these patients were expected to be dead by now, the outcomes of the Cytotron® therapy is outstanding. It is believed that in patients who are in a non-terminal situation (in better overall condition, with stronger immune system and not subject to the toxic conventional therapies with side effects) the efficacy of Cytotron® may be even more pronounced.